文献速递肺血管病与心包/心肌炎

去泛素化酶UCHL1缺陷减轻肺动脉高压

Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
PubMed 文献 · Circulation · 2024-05-02

该研究探讨去泛素化酶UCHL1在肺动脉高压(PAH)中的作用。在动物模型和患者内皮细胞中UCHL1表达升高,抑制或敲除UCHL1可减轻右心室肥厚、右室收缩压和血管重构,机制涉及减少AKT1。人遗传学数据提示UCHL1变异与肺内表达及心脏指数相关。

要点

  • UCHL1在PAH模型和患者内皮细胞中表达升高。
  • 抑制或敲除UCHL1可减轻PAH模型的血流动力学和重构指标。
  • UCHL1缺陷通过减少AKT1(尤其K63链接)发挥保护作用。

核心结论

  • UCHL1缺陷通过减少AKT1减轻肺动脉高压,提示新的治疗通路。

研究设计与样本

  • 研究结合动物肺动脉高压模型、人肺动脉内皮细胞及遗传关联分析。

主要发现

  • 动物模型和患者内皮细胞中UCHL1染色及蛋白表达增加。
  • LDN57444减少人肺动脉内皮细胞和平滑肌细胞增殖。
  • 三种PAH模型中抑制或敲除UCHL1减轻右心室肥厚、右室收缩压和闭塞性血管重构。
  • Uchl1-/-动物肺和内皮细胞中总Akt及活化Akt减少、泛素化Akt增加。
  • UCHL1沉默的人内皮细胞中K63链接AKT1减少、K48链接AKT1增加。

关键数值与推荐

  • rs9321变异与UCHL1基因低甲基化相关(n=5133)。
  • rs9321变异与肺内UCHL1基因表达增加相关(n=815)。
  • rs9321变异与患者心脏指数降低相关(n=796)。
  • Gadd45α-/-小鼠肺血管UCHL1和AKT1表达减少,缺氧性肺动脉高压减轻。

临床怎么用

  • UCHL1及其下游AKT1可能成为PAH治疗的新靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ubiquitin-proteasome system regulates protein degradation and the development of pulmonary arterial hypertension (PAH), but knowledge about the role of deubiquitinating enzymes in this process is limited. UCHL1 (ubiquitin carboxyl-terminal hydrolase 1), a deubiquitinase, has been shown to reduce AKT1 (AKT serine/threonine kinase 1) degradation, resulting in higher levels. Given that AKT1 is pathological in pulmonary hypertension, we hypothesized that UCHL1 deficiency attenuates PAH development by means of reductions in AKT1. METHODS: Tissues from animal pulmonary hypertension models as well as human pulmonary artery endothelial cells from patients with PAH exhibited increased vascular UCHL1 staining and protein expression. Exposure to LDN57444, a UCHL1-specific inhibitor, reduced human pulmonary artery endothelial cell and smooth muscle cell proliferation. Across 3 preclinical PAH models, LDN57444-exposed animals, Uchl1 knockout rats (Uchl1-/-), and conditional Uchl1 knockout mice (Tie2Cre-Uchl1fl/fl) demonstrated reduced right ventricular hypertrophy, right ventricular systolic pressures, and obliterative vascular remodeling. Lungs and pulmonary artery endothelial cells isolated from Uchl1-/- animals exhibited reduced total and activated Akt with increased ubiquitinated Akt levels. UCHL1-silenced human pulmonary artery endothelial cells displayed reduced lysine(K)63-linked and increased K48-linked AKT1 levels. RESULTS: Supporting experimental data, we found that rs9321, a variant in a GC-enriched region of the UCHL1 gene, is associated with reduced methylation (n=5133), increased UCHL1 gene expression in lungs (n=815), and reduced cardiac index in patients (n=796). In addition, Gadd45α (an established demethylating gene) knockout mice (Gadd45α-/-) exhibited reduced lung vascular UCHL1 and AKT1 expression along with attenuated hypoxic pulmonary hypertension. CONCLUSIONS: Our findings suggest that UCHL1 deficiency results in PAH attenuation by means of reduced AKT1, highlighting a novel therapeutic pathway in PAH.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Tang H, Gupta A, Morrisroe SA, et al. Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension. Circulation. 2024. PMID: 38695173. doi:10.1161/CIRCULATIONAHA.123.065304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。